BIOMETRIC CHARACTERIZATION OF AGENTS AND PATIENT SAFETY IN BIOLOGICAL INJECTION OR ADMINISTRATION

• US 20080167900A1
• Filed: 12/17/2007
• Published: 07/10/2008
• Est. Priority Date: 12/29/2006
• Status: Abandoned Application

• Current Assignee: Medrad Incorporated (Bayer AG)
• Original Assignee: Medrad Incorporated (Bayer AG)
• Inventors: Ranchod, Arun
• Application Number:
  US11/957,531
• Publication Number:
  US 20080167900A1
• Time in Patent Office: Days
• US Class Current: 705/2
• CPC Class Codes: G16H 10/40 for data related to laboratory analysis, e.g. patient specimen analysis
• CPC Class Codes: G16H 10/60 for patient-specific data, e.g. for electronic patient records
• CPC Class Codes: G16H 20/17 delivered via infusion or injection

Abstract

A system for confirming agent compatibility with a patient to whom the agent is to be delivered includes at least one detector adapted to read stored biometric data of the patient associated with the agent and to measure biometric data of the patient, and a controller adapted to compare the stored biometric data to the measured biometric data. The controller prevents the agent from being delivered to the patient if a mismatch occurs between the stored and the measured biometric data. The agent can, for example, include autologous cells harvested from the patient.

Claims

1. A system for confirming agent compatibility with a patient to whom the agent is to be delivered, the system comprising:

a container for holding the agent;

a memory device associated with the container, the memory device including stored biometric data of the patient;

at least one detector adapted to read the stored biometric data associated with the container and to measure biometric data from the patient;

a delivery system associated with the container and comprising a controller in communication with the at least one detector, the controller adapted to compare the stored biometric data to the measured biometric data to confirm the compatibility of the agent to the patient and to prevent delivery of the agent to the patient should the controller determine that the stored biometric data does not match the measured biometric data.

2. The system of claim 1 wherein the memory device is an EEPROM or an RFID tag.

3. The system of claim 1 wherein the container is a syringe or a bag.

4. The system of claim 1 wherein the at least one detector comprises two detectors, a first detector adapted to read the stored biometric data associated with the container and a second detector adapted to measure biometric data from the patient.

5. The system of claim 1 wherein the delivery system is an injector, a syringe pump or an infusion pump.

6. A method of delivering an agent to a patient, comprising:

associating biometric data from the patient with the agent;

measuring biometric data from the patient before the agent is delivered to the patient;

comparing the measured biometric data to the biometric data associated with the agent; and

upon determination of a mismatch between the measured biometric data and the biometric data associated with the agent, preventing the agent from being delivered to the patient.

7. The method of claim 6, further comprising:

maintaining association of the biometric data with the agent during processing thereof.

8. The method of claim 7 wherein the biometric data is transmitted between containers holding the agent or an intermediate of the agent during processing thereof.

9. The method of claim 6, further comprising:

creating a log of the location of the agent or an intermediate therefor over time.

10. The method of claim 9, further comprising:

upon determination of a mismatch between the measured biometric data and the biometric data associated with the agent, accessing the log of the location of a correct agent.

18. The method of claim 6, further comprising:

maintaining a record of the location of the agent.

19. The method of claim 18 wherein the agent comprises autologous cells harvested from the patient.

20. The method of claim 19 wherein the autologous cells are processed at a location other than the location at which the cells are harvested.

11. A method of delivering autologous cells, comprising:

associating a unique identifier with autologous cells harvested from a patient; and

before delivering autologous cells to the patient, determining if the unique identifier is associated therewith.

12. The method of claim 11 wherein the unique identifier comprises biometric data of the patient.

13. The method of claim 12, further comprising,

maintaining association of the biometric data with the autologous cells during processing thereof.

14. The method of claim 13 wherein the biometric data is transmitted between containers holding the autologous cells during processing thereof.

15. The method of claim 12, further comprising:

measuring biometric data from the patient before the autologous cells are delivered to the patient;

comparing the measured biometric data to the biometric data associated with the autologous cells; and

preventing the delivery of the autologous cells if there is a mismatch between the measured biometric data and the biometric data associated with the autologous cells.

16. The method of claim 15, further comprising:

creating a log of the location of the autologous cells over time.

17. The method of claim 16, further comprising:

upon determination of a mismatch between the measured biometric data and the biometric data associated with the autologous cells, accessing the log of the location of a correct autologous cells.